FR EN

Update of The Pioneer Project : 324 patients in the biomarker program, 29 patients in the umbrella clinical trial

Date : 31 August 2021
Category : MI Live,News,Pioneer Project


As of August 31th, 2021, 17 partner centers are recruiting patients for the biomarker component of The Pioneer Project:

Hôpital Nord/AP-HM, Hôpital Européen and Hôpital Saint Joseph (Marseille), Hôpital Larrey/Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Hôpital Sainte Musse (Toulon), Centre Hospitalier d’Annecy, Centre Hospitalier Vallées de l’Ariège (Foix), Hôpital Nord-Ouest (Villefranche-sur- Saône), Centre Hospitalier Henri Duffaut  (Avignon), Centre Hospitalier de Cahors, Centre Hospitalier du Pays d’Aix (Aix-en-Provence), Centre Hospitalier de Montauban, Centre Hospitalier de Bastia, Clinique Maymard (Bastia), ONCOGARD Nîmes and Alès.

Despite the difficult context of the COVID-19 pandemic, 361 patients have been screened, of which 324 have entered the biomarker component of the project (72%  of total inclusions). In parallel, 40 patients have been screened for and 29 have entered the PIONeeR umbrella clinical trial (24,2% of total inclusions).

PIONeeR BIOMARKERS

Centre

Number of patients screened

Number of patients included

CH Annecy Genevois

5

4

CH Avignon

8

4

CH Bastia

3

3

CH Cahors

3

3

CHIVA

7

5

CH Montauban

3

3

CH Nîmes

9

9

CH Toulon

25

23

CHG Aix Pertuis

15

15

CHU Marseille

169

150

CHU Toulouse

26

25

CH Villefranche-sur-Saône

9

9

CLC Léon Bérard

24

21

Clinique Maymard - Bastia

4

3

Hôpital Européen - Marseille

10

10

Hôpital Saint Joseph - Marseille

34

30

ONCOGARD

7

7

Total

361

324

PIONeeR TRIAL

Centre

Number of patients screened

Number of patients included

CHU Marseille

27

18

CHU Toulouse

7

6

CLC Léon Bérard

6

5

Total

40

29

 


Back